Imipramine Blue: A potent therapeutic regimen that suppresses breast cancer growth and metastasis
Ontology highlight
ABSTRACT: Imipramine Blue a novel inhibitor that we recently synthesiszed suppressed breast cancer growth and progression by silencing FOXM1 and its associated signaling. Breast cancer cell-line MDA-MB-231 treated with vehicle (DMSO) and IB, with 2 biological replciates each.
ORGANISM(S): Homo sapiens
SUBMITTER: Hung-I Chen
PROVIDER: E-GEOD-72363 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA